跳至主要内容
临床试验/NCT03287154
NCT03287154
已完成
不适用

Interest of tDCS in Help for Supporting Alcohol Abstinence

Centre Hospitalier Henri Laborit2 个研究点 分布在 1 个国家目标入组 90 人2017年2月8日

概览

阶段
不适用
干预措施
Active tDCS stimulations
疾病 / 适应症
Alcoholic Intoxication
发起方
Centre Hospitalier Henri Laborit
入组人数
90
试验地点
2
主要终点
Alcohol Abstinence
状态
已完成
最后更新
3个月前

概览

简要总结

The aim of the study is to evaluate in patients with alcohol disorder and forehand weaned the efficiency of 10 active tDCS sessions versus 10 sham (placebo) sessions in the support of abstinence at 3 months.

详细描述

The study takes place at one site (Henri Laborit Hospital, Poitiers, France) and is comparative, randomized and controlled. There are 2 groups : one group is receiving sessions of active tDCS (active group) whereas the second group is receiving sham (placebo) sessions (control group). Patients are randomized either in the active group or in the control group with a 1:1 ratio. An unblinded investigator is responsible of the stimulation part and could not evaluate the patients. The other investigators are blinded and could evaluate the patients. The study is going to evaluate the effect produces by stimulations in the two groups. In the placebo group, after the intensity has reached its maximal intensity (the same as in the active group), the stimulation is stopped after few seconds (30 seconds in mostly studies). This process allow patients in the placebo group to feel the same sensations as patients in the active group (indeed, tingles and itches are felt only during the first few seconds of stimulation). The poor duration of stimulation do not produces clinical effect. The study begins after a withdrawal period of 7 days +/- 3 days with 10 stimulations of 2 mA during 20 minutes from Monday to Friday during 2 weeks. Following these stimulation sessions, the patient will have 5 follow-up visits on site with an investigator and 2 phone follow-up. Visits: * Pre-inclusion visit * V0 visit (inclusion visit): takes place at the earliest 48 hours after stopping benzodiazepines used in the withdrawal period. * Treatment (weeks 0 and 1): 5 days of treatment per week during 2 weeks 2 arms : sham (placebo, 10 stimulations) vs active (10 stimulations of 2 mA) * Visit 1 (Week 4) : short nurse consultation * Visit 2 (Week 6) : short medical consultation * Visit 3 (Week 10) : short medical consultation * Visit 4 (Week 14) : long medical consultation * Visit 5 (Week 18) : nurse phone follow-up * Visit 6 (Week 22) : nurse phone follow-up * Visit 7 (Week 26) : long medical consultation

注册库
clinicaltrials.gov
开始日期
2017年2月8日
结束日期
2025年8月7日
最后更新
3个月前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • patient aged from 18 to 70 years old
  • patient free, without guardianship
  • absence of epileptic pathology
  • patient affiliated to the french health security or benefiting through a third party
  • signed informed consent after having received a clear and honest information on the study.
  • patient with a disorder linked to the use of alcohol (define by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) classification) clinically evaluated.
  • patient requesting for an alcohol withdrawal
  • patient able to read and write

排除标准

  • patient not affiliated to the french health security or not benefiting through a third party
  • woman in reproductive capacity without effective contraception (hormonal/mechanical: per os, injectable, transcutaneous, implantable, intra-uterine device or chirurgical: tubal ligation, hysterectomy, total ovariectomy) or breastfeeding
  • patient hospitalized under duress
  • patient with guardianship
  • somatic complications during the alcohol withdrawal phase
  • current psychiatric decompensation (mood disorder, suicide risk, psychotic disorders).
  • patient under benzodiazepines treatment
  • patient with scalp cutaneous lesion
  • history of cranial traumatism
  • patient with intra-cerebral metallic object

研究组 & 干预措施

Active tDCS stimulations

Patients in this arm will receive 10 tDCS active stimulations of 2 mA (1 stimulation per day from Monday to Friday during 2 weeks).

干预措施: Active tDCS stimulations

Sham tDCS

Patients in this arm will receive 10 sham stimulations (1 stimulation per day from Monday to Friday during 2 weeks). As soon as the power will have reached the maximal intensity as in the active arm, the stimulation will be stopped.

干预措施: Sham tDCS

结局指标

主要结局

Alcohol Abstinence

时间窗: 3 months

The primary outcome is to evaluate the interest of the transcranial Direct Current Stimulation (tDCS) for helping the abstinence support in addictive alcoholic patients.

次要结局

  • Alcohol consumption(6 months)
  • Tobacco consumption(6 months)
  • Executive functions assessments with the Go NoGo task.(6 months)
  • Executive functions assessments with the scale Barratt Impulsiveness Scale (BIS 11).(6 months)
  • Executive functions assessments with the Stroop test.(6 months)
  • Cognitive functions assessments with the Moca-test questionnaire.(6 months)
  • Executive functions assessments with the Wisconsin Card Sorting Test (WCST).(6 months)
  • Relapse control(6 months)
  • Anxiety-depression(6 months)
  • Safety assessment with adverse and/or intercurrent events analysis.(6 months)
  • Executive functions assessments with the IOWA Gambling Task (IGT).(6 months)

研究点 (2)

Loading locations...

相似试验